Does mean platelet volume (MPV) increase after iron infusion in patients with iron deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mean Platelet Volume (MPV) Does Not Increase After Iron Infusion

MPV levels remain unchanged following iron replacement therapy in patients with iron deficiency anemia, regardless of whether treatment achieves partial or complete response. 1

Key Evidence on MPV Response

The most recent high-quality study directly addressing this question found no change in MPV levels before and after iron treatment in patients with iron deficiency anemia and normal platelet counts 1. Specifically:

  • MPV levels remained stable at approximately 8.8-8.9 fL both before and after iron therapy, with no significant difference between partial responders (hemoglobin 10-12 g/dL) and complete responders (hemoglobin >12 g/dL) 1
  • This finding held true regardless of the route of iron administration (oral or intravenous) 2

What Actually Changes: Platelet Count and Other Parameters

While MPV remains stable, iron replacement therapy causes significant changes in other platelet parameters:

Platelet Count Decreases

  • Platelet count decreases in approximately 72% of patients following iron replacement therapy 2
  • Median platelet count drops from 299 × 10⁹/L at baseline to 265 × 10⁹/L at 3 months post-treatment (p < 0.0001) 2
  • This decrease occurs even in patients without baseline thrombocytosis 2

Thrombocytosis Resolution

  • Thrombocytosis (platelets >400 × 10⁹/L) is present in approximately 22% of iron deficiency anemia patients at baseline 2
  • Following iron replacement, thrombocytosis resolves in most patients, with only 5% maintaining elevated counts at 3 months 2

Other Platelet Parameters

  • Plateletcrit and platelet distribution width (PDW) decrease following iron therapy 1
  • There is an inverse correlation between MPV and platelet count (r = -0.5, p < 0.001), meaning as platelet count decreases with treatment, MPV tends to remain stable or show minimal compensatory changes 1

Clinical Mechanism

The relationship between iron deficiency and platelet parameters is mediated through:

  • Serum iron and transferrin saturation are the key iron metabolism parameters affecting platelet count 3
  • More severe iron deficiency correlates with higher platelet counts 3
  • The mechanism may involve increased erythropoietin production in iron deficiency states, which can stimulate megakaryopoiesis 4

Important Clinical Caveats

Intravenous iron administration may actually decrease platelet counts more than oral iron in some contexts. Data from hemodialysis patients showed platelet counts decreased by 29,000/μL with IV iron versus no change without iron (p = 0.017) 4. This suggests IV iron may have additional effects on platelet production beyond simply correcting iron deficiency.

The absence of MPV change does not mean platelet function is normal. Studies show that platelet aggregation (particularly collagen-induced and ADP-induced) is actually diminished in iron deficiency anemia and improves with treatment 5, even though MPV remains unchanged.

Monitoring Recommendations

When treating iron deficiency anemia:

  • Monitor platelet count at 3 months post-treatment, as this is when the most significant changes occur 2
  • Do not rely on MPV as a marker of treatment response, as it does not change significantly 1
  • Expect platelet count normalization in patients with baseline thrombocytosis within 3 months of adequate iron replacement 2

References

Research

Diminished platelet aggregation in patients with iron deficiency anemia.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.